News Gates Foundation puts $2.5bn into 'ignored' women's health The Gates Foundation is ramping up support for women's health research, pumping $2.5bn into new projects in this 'ignored, underfunded' area of R&D.
R&D Grants for funding pharmaceutical research: Growing without ... Whilst equity investment is likely to be central to the funding strategy of many early-stage biotechs, grant funding can be a very useful alternative.
Market Access Political uncertainties, tariffs, funding crunch? LSX World ... The weather was hot in London for this year’s LSX World Congress – but what was the atmosphere like at Europe’s leading partnering, strategy, and investment event?
Market Access VCs upbeat about European life sciences market, despite unce... It has been a curious start to the year for pharma and biotech investment.
News UK's long-term R&D investment policy welcomed The decision by the UK to set new 10-year budgets for public R&D funding has received a positive response from academia and the pharma industry.
News RFK Jr defends HHS cuts, measles stance in Congress hearings HHS Secretary Robert F Kennedy Jr would not explicitly endorse measles vaccines at Congressional hearings, and deflected questions on department cuts.
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.